Differential Effects of Caffeine on Dopamine and Acetylcholine Transmission in Brain Areas of Drug-naive and Caffeine-pretreated Rats

Neuropsychopharmacology

Volumn 27, Issue 2, 2002, Pages 182-193

  Acquas, Elio ^a   Tanda, Gianluigi ^a   Di Chiara, Gaetano ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

Acetylcholine; Caffeine; Dopamine; Microdialysis; Nucleus Accumbens; Prefrontal cortex

Indexed keywords

5 AMINO 2 (2 FURYL) 7 (2 PHENYLETHYL)PYRAZOLO[4,3 E][1,2,4]TRIAZOLO[1,5 C]PYRIMIDINE; 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; ACETYLCHOLINE; ADENOSINE A1 RECEPTOR AGONIST; ADENOSINE A2 RECEPTOR ANTAGONIST; CAFFEINE; DOPAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN LEVEL; CONTROLLED STUDY; DOPAMINERGIC TRANSMISSION; DOSE RESPONSE; DRUG ABUSE; DRUG EFFECT; DRUG SENSITIVITY; DRUG TOLERABILITY; LOCOMOTION; MALE; MICRODIALYSIS; NEUROTRANSMISSION; NONHUMAN; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT;

ACETYLCHOLINE; ANIMALS; BEHAVIOR, ANIMAL; CAFFEINE; CENTRAL NERVOUS SYSTEM STIMULANTS; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; EXTRACELLULAR SPACE; INJECTIONS, INTRAPERITONEAL; MALE; MICRODIALYSIS; NEUROPROTECTIVE AGENTS; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; PRESYNAPTIC TERMINALS; PYRIMIDINES; RATS; RATS, SPRAGUE-DAWLEY; SYNAPTIC TRANSMISSION; TRIAZOLES; XANTHINES;

EID: 0036289236     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(02)00290-7     Document Type: Article

References (47)

1. Conditioned and unconditioned stimuli increase frontal cortical and hippocampal acetylcholine release: Effects of novelty, habituation, and fear
2. Cocaine and caffeine: Conditioned place preference, locomotor activity, and addictivity
3. A1, but not A2A, adenosine receptors modulate electrically stimulated [14C]acetylcholine release from rat cortex
4. Binding of the A1-selective adenosine antagonist 8-cyclopentyl-1,3- dipropylxanthine to rat brain membranes
5. Reciprocal changes in dopamine responsiveness in the nucleus accumbens shell and core and in the dorsal caudate-putamen in rats sensitized to morphine
6. Differential changes in accumbens shell and core dopamine in behavioral sensitization to nicotine
7. Caffeine enhances acetylcholine release in the hippocampus in vivo by a selective interaction with adenosine A1 receptors
8. Caffeine tolerance: Behavioral, electrophysiological and neurochemical evidence
9. Adaptation of the quantitative 2-[14C]deoxyglucose method for use in freely moving rats
10. Measurement of acetylcholine release in freely moving rats by means of automated intracerebral dialysis
11. Cholinergic activity in the rat hippocampus, cortex and striatum correlates with locomotor activity: An in vivo microdialysis study
12. A motivational learning hypothesis of the role of mesolimbic dopamine in compulsive drug use
13. Drug addiction as dopamine-dependent associative learning disorder
14. Tissue distribution of adenosine receptor mRNAs in the rat
15. Adenosine-dopamine interactions in the brain
16. Antagonistic interaction between adenosine A2A receptors and dopamine D2 receptors in the ventral striopallidal system. Implications for the treatment of schizophrenia
17. Cholinergic mechanisms in learning, memory and dementia: A review of recent evidence
18. Striatal adenosine A2A receptors - where are they? What do they do?
19. Actions of caffeine in the brain with special reference to factors that contribute to its widespread use
20. Physical dependence increases the relative reinforcing effects of caffeine versus placebo
21. Caffeine - A drug of abuse? In: Bloom FE, Kupfer DJ. (eds), New York, Raven Press
22. Specificity in the projection patterns of accumbal core and shell in the rat
23. Piecing together the puzzle of basal forebrain anatomy
24. Autoradiographic evidence for multiple CNS binding sites for adenosine derivatives
25. Central cholinergic pathways in the rat: An overview based on an alternative nomenclature (Ch 1-Ch6 )
26. Acetylcholine release in the rat hippocampus as measured by the microdialysis method correlates with motor activity and exhibits a diurnal variation
27. Bidirectional modulation of stimulated cortical acetylcholine release by benzodiazepine receptor ligands
28. Are we dependent upon coffee and caffeine? A review on human and animal data
29. Determination of the effects of caffeine and carbamazepine on striatal dopamine release by in vivo microdialysis
30. Neuropharmacology of the adenosine A2A receptors
31. Adenosine receptors
32. Increased acetylcholine release in the rat medial prefrontal cortex during performance of a visual attentional task
33. Caffeine place conditioning in rats: Comparison with cocaine and ethanol
34. Intravenous cocaine, morphine, and amphetamine preferentially increase extracellular dopamine in the "shell" as compared with the "core" of the rat nucleus accumbens
35. Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs
36. Adenosine: A mediator of the sleep-inducing effects of prolonged wakefulness
37. Role of adenosine in behavioral state modulation: A microdialysis study in the freely moving cat
38. Adenosine inhibition of mesopontine cholinergic neurons: Implications for EEG arousal
39. Cortical cholinergic inputs mediating arousal, attentional processing and dreaming: Differential afferent regulation of the basal forebrain by telencephalic and brainstem afferents
40. Distribution and organization of cholinergic neurons in the rat forebrain demonstrated by computer-aided data acquisition and three-dimensional reconstruction
41. Adenosinergic modulation of basal forebrain and preoptic/anterior hypothalamic neuronal activity in the control of behavioral state
42. The stimulatory action and the development of tolerance to caffeine is associated with alterations in gene expression in specific brain regions
43. Mianserin markedly and selectively increases extracellular dopamine in the prefrontal cortex as compared to the nucleus accumbens of the rat
44. Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism
45. The non-xanthine heterocyclic compound SCH 58261 is a new potent and selective A2a adenosine receptor antagonist